“…Product innovation involves the introduction of new or significantly improved goods or services for NCD prevention and management (i.e., polypills, improved distribution methods) (Hancock et al, 2011 ; Nari Kahle et al, 2013 ; Plum et al, 2020 ; U.S. Department of State, 2011 ) and development of new health information or communication technology systems to improve data collection and monitoring (Doshi et al, 2021 ; Engelgau et al, 2016 ; Ganju et al, 2020 ; Global Systems for Mobile Communications, 2019 ; Rouleau et al, 2017 ; Shuvo et al, 2015 ; WHO, 2008 ). It also involves anticipating NCD-related needs and developing innovative technology that meets them (da Cruz Paula et al, 2020 ) and the upgrading of existing tools, devices, and technology to enhance services (Checkley et al, 2014 ; IFC, 2011 ; U.S. Department of State, 2011 ).…”